Pharma News

Through generic medicine competition, twice as many patients were able to get treatment without any impact on the treatment cost, according to the conclusions of the IMS Institute for Healthcare Infor...

The major depressive disorder (MDD) market, which covers various forms of depression and seasonal affective disorder, is set to rise from $3.

The FDA named two European drug manufacturers--Delarange Cosmetics & Healthcare of the Netherlands and Wallace Cameron of the U.

SOUTHAMPTON, UK I October 12, 2016 I Synairgen plc (LSE.

As part of its efforts to expand access and make certain drugs more affordable for the treatment of a variety diseases and conditions, the World Health Organization is inviting API manufacturers to ap...

LEXINGTON, MA, USA I October 11, 2016 I Curis, Inc.

US regulators have approved Lundbeck's Carnexiv, the first intravenous formulation of epilepsy drug carbamazepine.

Exelixis's drug Cabometyx outperformed Pfizer's Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it has the potential to become a first-line treatment, rese...

Takeda Pharmaceutical Company Limited and Crescendo Biologics Limited said early Monday they entered into a cancer drug development partnership worth up to $36 million and as much as $754 million in a...

The pharmaceutical market in the United Arab Emirates (UAE) is set to grow from just over $3 billion in 2015 to $5.

When Theranos CEO Elizabeth Holmes presented a new device at a conference this summer, it seemed to be a bid to distract from the company’s much-criticized blood-testing tech.

DEERFIELD, Ill.